Datasets:

stanpony

/

fine_tune_patient_diagnoses

like 1

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [10-20). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 59. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 276. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 255. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [20-30). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 11. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 2. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 648. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): V27. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [30-40). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 8. The secondary diagnosis (coded as first three digits of ICD9): 250.43. Additional secondary diagnosis (coded as first three digits of ICD9): 403. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 51. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 197. The secondary diagnosis (coded as first three digits of ICD9): 157. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 31. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 70. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 21. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): V45. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 73. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 492. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 13. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 68. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 28. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 398. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 38. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [90-100). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to SNF. admission_source: Transfer from a hospital. Number of days between admission and discharge: 12. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 33. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 434. The secondary diagnosis (coded as first three digits of ICD9): 198. Additional secondary diagnosis (coded as first three digits of ICD9): 486. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: Steady. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 62. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 157. The secondary diagnosis (coded as first three digits of ICD9): 288. Additional secondary diagnosis (coded as first three digits of ICD9): 197. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Up. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 60. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 250.43. Additional secondary diagnosis (coded as first three digits of ICD9): 250.6. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: Up. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 10. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 55. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 31. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 49. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 2. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 518. The secondary diagnosis (coded as first three digits of ICD9): 998. Additional secondary diagnosis (coded as first three digits of ICD9): 627. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 12. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 75. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 999. The secondary diagnosis (coded as first three digits of ICD9): 507. Additional secondary diagnosis (coded as first three digits of ICD9): 996. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 45. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 29. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 682. The secondary diagnosis (coded as first three digits of ICD9): 174. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 35. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 23. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 402. The secondary diagnosis (coded as first three digits of ICD9): 425. Additional secondary diagnosis (coded as first three digits of ICD9): 416. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: ?. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to home with home health service. admission_source: Clinic Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 42. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 23. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 737. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 714. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Down. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: ?. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 36. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 572. The secondary diagnosis (coded as first three digits of ICD9): 456. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 582. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to home with home health service. admission_source: Physician Referral. Number of days between admission and discharge: 11. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 42. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): V57. The secondary diagnosis (coded as first three digits of ICD9): 715. Additional secondary diagnosis (coded as first three digits of ICD9): V43. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 19. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 189. The secondary diagnosis (coded as first three digits of ICD9): 496. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Other. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 33. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 64. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 427. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 25. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 996. The secondary diagnosis (coded as first three digits of ICD9): 585. Additional secondary diagnosis (coded as first three digits of ICD9): 250.01. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [20-30). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 10. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 277. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 263. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another short term hospital. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 410. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another type of inpatient care institution. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 462. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 27. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 996. The secondary diagnosis (coded as first three digits of ICD9): 999. Additional secondary diagnosis (coded as first three digits of ICD9): 250.01. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to home with home health service. admission_source: Clinic Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 37. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 473. The secondary diagnosis (coded as first three digits of ICD9): 996. Additional secondary diagnosis (coded as first three digits of ICD9): 482. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Expired. admission_source: Clinic Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 585. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 41. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 411. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: Steady. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 33. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 174. The secondary diagnosis (coded as first three digits of ICD9): 135. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 33. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 486. The secondary diagnosis (coded as first three digits of ICD9): 244. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 22. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 998. The secondary diagnosis (coded as first three digits of ICD9): 41. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 996. The secondary diagnosis (coded as first three digits of ICD9): 403. Additional secondary diagnosis (coded as first three digits of ICD9): 250.41. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 36. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 511. The secondary diagnosis (coded as first three digits of ICD9): 571. Additional secondary diagnosis (coded as first three digits of ICD9): 585. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 13. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): V57. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 781. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 59. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 496. Additional secondary diagnosis (coded as first three digits of ICD9): 278. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Expired. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 72. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 27. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 432. The secondary diagnosis (coded as first three digits of ICD9): 997. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 10. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 626. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 998. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to another type of inpatient care institution. admission_source: Transfer from a hospital. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 25. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 2. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 250.01. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to SNF. admission_source: Transfer from a hospital. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 2. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 295. The secondary diagnosis (coded as first three digits of ICD9): 599. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Up. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 65. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 424. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to home with home health service. admission_source: Transfer from a hospital. Number of days between admission and discharge: 11. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 67. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 25. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 491. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 998. The secondary diagnosis (coded as first three digits of ICD9): 553. Additional secondary diagnosis (coded as first three digits of ICD9): 568. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 55. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.6. The secondary diagnosis (coded as first three digits of ICD9): 707. Additional secondary diagnosis (coded as first three digits of ICD9): 682. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 278. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: ?. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 54. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 4. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 618. The secondary diagnosis (coded as first three digits of ICD9): 997. Additional secondary diagnosis (coded as first three digits of ICD9): 618. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 58. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 182. The secondary diagnosis (coded as first three digits of ICD9): 286. Additional secondary diagnosis (coded as first three digits of ICD9): 250.02. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to home with home health service. admission_source: Clinic Referral. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 37. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 250.7. The secondary diagnosis (coded as first three digits of ICD9): 440. Additional secondary diagnosis (coded as first three digits of ICD9): 403. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 36. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 845. The secondary diagnosis (coded as first three digits of ICD9): 493. Additional secondary diagnosis (coded as first three digits of ICD9): 305. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to home with home health service. admission_source: Transfer from a hospital. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 58. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 21. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 423. The secondary diagnosis (coded as first three digits of ICD9): 242. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to home with home health service. admission_source: Transfer from a hospital. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 2. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 808. The secondary diagnosis (coded as first three digits of ICD9): 70. Additional secondary diagnosis (coded as first three digits of ICD9): 250.01. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another short term hospital. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 45. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: Steady. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 64. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 250.03. Additional secondary diagnosis (coded as first three digits of ICD9): 707. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 57. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 722. The secondary diagnosis (coded as first three digits of ICD9): 357. Additional secondary diagnosis (coded as first three digits of ICD9): 496. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: Steady. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Expired. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 58. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 403. The secondary diagnosis (coded as first three digits of ICD9): V45. Additional secondary diagnosis (coded as first three digits of ICD9): 599. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: ?. Gender: Female. Age: [90-100). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to SNF. admission_source: Clinic Referral. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 43. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.7. The secondary diagnosis (coded as first three digits of ICD9): 440. Additional secondary diagnosis (coded as first three digits of ICD9): 715. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [10-20). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another type of inpatient care institution. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 51. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 4. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.11. The secondary diagnosis (coded as first three digits of ICD9): ?. Additional secondary diagnosis (coded as first three digits of ICD9): ?. Number of diagnosis: 1. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 25. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 424. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 32. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 424. Additional secondary diagnosis (coded as first three digits of ICD9): 424. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 55. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 784. The secondary diagnosis (coded as first three digits of ICD9): 511. Additional secondary diagnosis (coded as first three digits of ICD9): 518. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 12. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 83. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 32. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 189. The secondary diagnosis (coded as first three digits of ICD9): 403. Additional secondary diagnosis (coded as first three digits of ICD9): V45. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 31. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 440. The secondary diagnosis (coded as first three digits of ICD9): 250.03. Additional secondary diagnosis (coded as first three digits of ICD9): 582. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 14. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 28. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 28. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 151. The secondary diagnosis (coded as first three digits of ICD9): 196. Additional secondary diagnosis (coded as first three digits of ICD9): 553. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 51. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 58. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 396. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged/transferred to SNF. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Orthopedics. Number of lab tests performed during the encounter: 57. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 21. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 715. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Expired. admission_source: Transfer from a hospital. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 35. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 997. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 403. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 41. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 2. The primary diagnosis (coded as first three digits of ICD9): 198. The secondary diagnosis (coded as first three digits of ICD9): 197. Additional secondary diagnosis (coded as first three digits of ICD9): 197. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Left AMA. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 58. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 998. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 424. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 59. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 564. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): 794. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Other. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 64. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 585. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 39. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 69. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 25. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 250.52. Additional secondary diagnosis (coded as first three digits of ICD9): 411. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: ?. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to SNF. admission_source: Clinic Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 10. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 812. The secondary diagnosis (coded as first three digits of ICD9): 496. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 69. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 425. Additional secondary diagnosis (coded as first three digits of ICD9): 250.02. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 38. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 250.7. The secondary diagnosis (coded as first three digits of ICD9): 440. Additional secondary diagnosis (coded as first three digits of ICD9): V42. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to home with home health service. admission_source: Clinic Referral. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 21. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 398. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 27. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 996. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 6. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 997. The secondary diagnosis (coded as first three digits of ICD9): 577. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 65. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 403. The secondary diagnosis (coded as first three digits of ICD9): 535. Additional secondary diagnosis (coded as first three digits of ICD9): 531. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 19. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 996. The secondary diagnosis (coded as first three digits of ICD9): 413. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 64. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 21. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 38. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 55. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 23. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 511. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Other. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 6. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 590. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: ?. Gender: Male. Age: [30-40). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to home with home health service. admission_source: Transfer from a hospital. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 72. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 556. The secondary diagnosis (coded as first three digits of ICD9): 285. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: Steady. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Expired. admission_source: Clinic Referral. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 73. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 23. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 486. The secondary diagnosis (coded as first three digits of ICD9): 511. Additional secondary diagnosis (coded as first three digits of ICD9): 250.02. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 22. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 413. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another short term hospital. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 59. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 411. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 490. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 31. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 578. The secondary diagnosis (coded as first three digits of ICD9): 53. Additional secondary diagnosis (coded as first three digits of ICD9): 562. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 707. The secondary diagnosis (coded as first three digits of ICD9): 780. Additional secondary diagnosis (coded as first three digits of ICD9): 250.8. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Other. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 96. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.32. The secondary diagnosis (coded as first three digits of ICD9): 518. Additional secondary diagnosis (coded as first three digits of ICD9): 482. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 427. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 35. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 26. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 433. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): V45. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>

<s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days': 'Patient's context Race: ?. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 39. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 21. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): V58. The secondary diagnosis (coded as first three digits of ICD9): 150. Additional secondary diagnosis (coded as first three digits of ICD9): 496. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s>